title: Percutaneous Treatment of Lymphatic Malformations.
abstract: Lymphatic malformations are slow-flow vascular anomalies composed of dilated lymphatic channels and cysts of varying sizes. Percutaneous treatments, particularly sclerotherapy, play an important role in the treatment of these lesions, often obviating the need for surgical intervention. Owing to the complex nature of these lesions, a multidisciplinary approach should be used to guide diagnosis and management. This submission focuses on the workup and treatment of pediatric lymphatic malformations at our institution, with a focus on sclerotherapy. Therapeutic outcomes and the management of postprocedural complications are also discussed.
authors.affiliation: Department of Radiology, The Children's Hospital of Philadelphia, University of Pennsylvania, Philadelphia, PA. Electronic address: acordm@email.chop.edu.
authors.forename: Michael
authors.initials: M
authors.lastname: Acord
authors.affiliation: Department of Radiology, The Children's Hospital of Philadelphia, University of Pennsylvania, Philadelphia, PA.
authors.forename: Abhay S
authors.initials: AS
authors.lastname: Srinivasan
authors.affiliation: Department of Radiology, The Children's Hospital of Philadelphia, University of Pennsylvania, Philadelphia, PA.
authors.forename: Anne Marie
authors.initials: AM
authors.lastname: Cahill
mesh_terms: D002675:Child, Preschool; D005260:Female; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D044148:Lymphatic Abnormalities / Q000000981:diagnostic imaging / Q000503:physiopathology / Q000628:therapy*; D008208:Lymphatic System / Q000002:abnormalities* / Q000000981:diagnostic imaging / Q000503:physiopathology; D008279:Magnetic Resonance Imaging; D008297:Male; D011237:Predictive Value of Tests; D012307:Risk Factors; D012597:Sclerosing Solutions / Q000008:administration & dosage* / Q000009:adverse effects; D015911:Sclerotherapy / Q000009:adverse effects / Q000379:methods*; D016896:Treatment Outcome
chemical_list: D012597:Sclerosing Solutions
keywords: Lymphatic malformations; Pediatric; Sclerotherapy